Literature DB >> 15046738

Annexin 1 and the regulation of endocrine function.

Christopher D John1, Helen C Christian, John F Morris, Roderick J Flower, Egle Solito, Julia C Buckingham.   

Abstract

Annexin 1 (ANXA1) was first identified as a mediator of the anti-inflammatory actions of glucocorticoids in the host defence system. Subsequent work revealed that this protein fulfils a wider brief and it is now recognized as an important signalling intermediate in a variety of other systems. Here, we consider the role of ANXA1 in the endocrine system, placing particular emphasis on new insights into the mechanisms and functional significance of the secondary processing of ANXA1, the processes that control the intracellular and transmembrane trafficking of the molecule and the molecular mechanisms of ANXA1 action that have identified a novel role for the protein as a paracrine/juxtacrine mediator of the non-genomic actions of glucocorticoids in the neuroendocrine system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15046738     DOI: 10.1016/j.tem.2004.02.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  22 in total

1.  Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface.

Authors:  E Solito; H C Christian; M Festa; A Mulla; T Tierney; R J Flower; J C Buckingham
Journal:  FASEB J       Date:  2006-05-23       Impact factor: 5.191

Review 2.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

Review 3.  Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.

Authors:  Mauro Perretti; Jesmond Dalli
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

Review 4.  Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.

Authors:  Gloria Laryea; Lisa Muglia; Melinda Arnett; Louis J Muglia
Journal:  Front Neuroendocrinol       Date:  2014-09-27       Impact factor: 8.606

Review 5.  Annexin 1, glucocorticoids, and the neuroendocrine-immune interface.

Authors:  Julia C Buckingham; Christopher D John; Egle Solito; Tanya Tierney; Roderick J Flower; Helen Christian; John Morris
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

6.  Gene deletion reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release in epididymal adipose tissue.

Authors:  James P Warne; Christopher D John; Helen C Christian; John F Morris; Roderick J Flower; David Sugden; Egle Solito; Glenda E Gillies; Julia C Buckingham
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-07-11       Impact factor: 4.310

7.  Lack of annexin 1 results in an increase in corticotroph number in male but not female mice.

Authors:  J F Morris; S Omer; E Davies; E Wang; C John; T Afzal; S Wain; J C Buckingham; R J Flower; H C Christian
Journal:  J Neuroendocrinol       Date:  2006-11       Impact factor: 3.627

8.  Modulation of mouse macrophage proteome induced by Toxoplasma gondii tachyzoites in vivo.

Authors:  D H Zhou; Z G Yuan; F R Zhao; H L Li; Y Zhou; R Q Lin; F C Zou; H Q Song; M J Xu; X Q Zhu
Journal:  Parasitol Res       Date:  2011-05-17       Impact factor: 2.289

9.  Glucocorticoid-stimulated, transcription-independent release of annexin A1 by cochlear Hensen cells.

Authors:  F Kalinec; P Webster; A Maricle; D Guerrero; D N Chakravarti; B Chakravarti; R Gellibolian; G Kalinec
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

10.  Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.

Authors:  Samia Yazid; Egle Solito; Helen Christian; Simon McArthur; Nicolas Goulding; Roderick Flower
Journal:  Biochem Pharmacol       Date:  2009-03-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.